Cronos Group Inc. Files Q1 2025 10-Q Report
Ticker: CRON · Form: 10-Q · Filed: 2025-05-08T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, reporting
TL;DR
Cronos Group Q1 2025 10-Q filed. Financials updated.
AI Summary
Cronos Group Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and disclosures relevant to investors are presented in this report.
Why It Matters
This filing provides investors with the latest financial health and operational performance of Cronos Group Inc., crucial for making informed investment decisions.
Risk Assessment
Risk Level: medium — As a publicly traded company in the cannabis sector, Cronos Group faces inherent regulatory, market, and operational risks.
Key Numbers
- 2025-03-31 — Report End Date (Indicates the end of the reporting period for the 10-Q.)
- 2025-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2024-12-31 — Previous Year End (Provides a comparative point to the current reporting period.)
Key Players & Entities
- Cronos Group Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — Period of report for the 10-Q
- 20250508 (date) — Filing date of the 10-Q
- PharmaCan Capital Corp. (company) — Former company name of Cronos Group Inc.
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the filing covers the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
The filing date (FILED AS OF DATE) is 20250508.
What was the company's former name?
The former company name was PharmaCan Capital Corp., with a date of name change on 20151021.
What is the Standard Industrial Classification code for Cronos Group Inc.?
The SIC code is 2833, categorized under MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.
What is the fiscal year end for Cronos Group Inc.?
The fiscal year end is 1231.
From the Filing
0001656472-25-000058.txt : 20250508 0001656472-25-000058.hdr.sgml : 20250508 20250508073320 ACCESSION NUMBER: 0001656472-25-000058 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 94 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250508 DATE AS OF CHANGE: 20250508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 25923902 BUSINESS ADDRESS: STREET 1: 4491 CONCESSION RD 12 CITY: STAYNER STATE: A6 ZIP: L0M 1S0 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 6D - 7398 YONGE ST STREET 2: PMB 732 CITY: THORNHILL STATE: A6 ZIP: L4J 8J2 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 10-Q 1 cron-20250331.htm 10-Q cron-20250331 false 2025 Q1 0001656472 --12-31 00-0000000 P3Y P3Y P3Y 1 1 xbrli:shares iso4217:USD iso4217:USD xbrli:shares cron:segment xbrli:pure iso4217:CAD iso4217:ILS iso4217:CAD xbrli:shares cron:shareholder cron:complaint cron:defendant 0001656472 2025-01-01 2025-03-31 0001656472 2025-05-05 0001656472 2025-03-31 0001656472 2024-12-31 0001656472 2024-01-01 2024-03-31 0001656472 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-12-31 0001656472 us-gaap:RetainedEarningsMember 2024-12-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001656472 us-gaap:NoncontrollingInterestMember 2024-12-31 0001656472 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001656472 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001656472 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-03-31 0001656472 us-gaap:RetainedEarningsMember 2025-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2025-03-31 0001656472 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-12-31 0001656472 us-gaap:RetainedEarningsMember 2023-12-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001656472 us-gaap:NoncontrollingInterestMember 2023-12-31 0001656472 2023-12-31 0001656472 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001656472 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001656472 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-03-31 0001656472 us-gaap:RetainedEarningsMember 2024-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2024-03-31 0001656472 2024-03-31 0001656472 cron:CannabisFlowerMember 2025-01-01 2025-03-31 0001656472 cron:CannabisFlowerMember 2024-01-01 2024-03-31 0001656472 cron:CannabisExtractsMember 2025-01-01 2025-03-31 0001656472 cron:CannabisExtractsMember 2024-01-01 2024-03-31 0001656472 us-gaap:ProductAndServiceOtherMember 2025-01-01 2025-03-31 0001656472 us-gaap:ProductAndServiceOtherMember 2024-01-01 2024-03-31 0001656472 country:CA 2025-01-01 2025-03-31 0001656472 country:CA 2024-01-01 2024-03-31 0001656472 country:IL 2025-01-01 2025-03-31 0001656472 country:IL 2024-01-01 2024-03-31 0001656472 cron:OtherCountriesMember 2025-01-01 2025-03-31 0001656472 cron:OtherCountriesMember 2024-01-01 2024-03-31 0001656472 2024-01-01 2024-12-31 0001656472 cron:OneCustomerMember us-gaap:CreditConcentrationRiskMember us-gaap:AccountsReceivableMember 2025-01-01 2025-03-31 0001656472 cron:OneCustomerMember us-gaap:CreditConcentrationRiskMember us-ga